GENERIC DRUGS MARKET ANALYSIS

Generic Drugs Market, By Drug Type (Monoclonal Antibodies, Cytokines, Vaccines, Insulin, Peptide Hormone, Immunoglobulin, Peptide Antibiotics, Blood Factors, and Others), By Therapeutic Application (Oncology, Cardiovascular Diseases, Neurology, Infectious Diseases, Musculoskeletal Diseases, and Others), By Route of Administration (Oral, Topical, Injectable, Intra-venous, and Others), and By Geography- (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI1132
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

New drug launches and market approvals from the U.S. FDA to generic manufacturers are bolstering growth of the generic drugs market. For instance, in December 2017, Zydus Pharmaceuticals — a subsidiary of Cadila Healthcare — received U.S. FDA approval to market Pramipexole Dihydrochloride extended-release tablets for the treatment of Parkinson’s disease in the U.S. market.